These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29275953)

  • 41. Personalized medicine for cystic fibrosis: establishing human model systems.
    Mou H; Brazauskas K; Rajagopal J
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S14-23. PubMed ID: 26335952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic fibrosis: toward personalized therapies.
    Ikpa PT; Bijvelds MJ; de Jonge HR
    Int J Biochem Cell Biol; 2014 Jul; 52():192-200. PubMed ID: 24561283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy.
    Elborn JS; Davies J; Mall MA; Flume PA; Plant B
    J Cyst Fibros; 2017 Jan; 16(1):163-164. PubMed ID: 27986495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel therapeutic approaches for cystic fibrosis.
    Wilschanski M
    Discov Med; 2013 Feb; 15(81):127-33. PubMed ID: 23449115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CFTR: cystic fibrosis and beyond.
    Mall MA; Hartl D
    Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.
    Villate-Beitia I; Zarate J; Puras G; Pedraz JL
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precision Genomic Medicine in Cystic Fibrosis.
    Chang EH; Zabner J
    Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New drugs for cystic fibrosis.
    Wilschanski M; Kerem E
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1285-92. PubMed ID: 21745147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Molecular Genetics and the long road to treating cystic fibrosis.
    Harris A
    Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oligonucleotide-based therapies for cystic fibrosis.
    Kreda SM
    Curr Opin Pharmacol; 2022 Oct; 66():102271. PubMed ID: 35988291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
    Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
    Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.
    Rowbotham NJ; Daniels TE
    Pediatr Pulmonol; 2022 Feb; 57 Suppl 1():S50-S59. PubMed ID: 34672434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.
    Bell SC; De Boeck K; Amaral MD
    Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress towards next-generation therapeutics for cystic fibrosis.
    O'Neil DA; Fraser-Pitt D
    Future Med Chem; 2014 Jun; 6(9):1067-79. PubMed ID: 25068988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
    de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
    J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macromolecular interactions and ion transport in cystic fibrosis.
    Guggino WB; Banks-Schlegel SP
    Am J Respir Crit Care Med; 2004 Oct; 170(7):815-20. PubMed ID: 15447951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene therapy for cystic fibrosis: which postman, which box?
    Middleton PG; Alton EW
    Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.